A detailed history of Choreo, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Choreo, LLC holds 54,667 shares of GILD stock, worth $5.11 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
54,667
Previous 45,501 20.14%
Holding current value
$5.11 Million
Previous $3.12 Million 46.81%
% of portfolio
0.07%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$66.59 - $83.99 $610,363 - $769,852
9,166 Added 20.14%
54,667 $4.58 Million
Q2 2024

Aug 06, 2024

BUY
$63.15 - $72.88 $2.24 Million - $2.59 Million
35,538 Added 356.7%
45,501 $3.12 Million
Q1 2024

May 02, 2024

BUY
$71.58 - $87.29 $129,989 - $158,518
1,816 Added 22.29%
9,963 $729,000
Q4 2023

Feb 05, 2024

BUY
$73.27 - $83.09 $208,379 - $236,307
2,844 Added 53.63%
8,147 $659,000
Q3 2023

Nov 08, 2023

BUY
$73.94 - $80.67 $10,499 - $11,455
142 Added 2.75%
5,303 $397,000
Q2 2023

Aug 04, 2023

SELL
$76.01 - $86.7 $5,472 - $6,242
-72 Reduced 1.38%
5,161 $397,000
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $404,563 - $460,922
5,233 New
5,233 $434,000
Q4 2018

Jun 04, 2020

SELL
$60.54 - $79.0 $213,524 - $278,633
-3,527 Closed
0 $0
Q3 2018

Jun 04, 2020

SELL
$71.28 - $78.92 $47,329 - $52,402
-664 Reduced 15.84%
3,527 $272,000
Q2 2018

Jun 04, 2020

SELL
$64.88 - $75.68 $129,435 - $150,981
-1,995 Reduced 32.25%
4,191 $297,000
Q1 2018

Jun 04, 2020

BUY
$72.84 - $88.8 $32,850 - $40,048
451 Added 7.86%
6,186 $466,000
Q4 2017

Jun 04, 2020

BUY
$71.15 - $83.52 $11,312 - $13,279
159 Added 2.85%
5,735 $411,000
Q3 2017

Jun 04, 2020

BUY
$72.11 - $85.47 $79,032 - $93,675
1,096 Added 24.46%
5,576 $452,000
Q2 2017

Jun 04, 2020

SELL
N/A
-941 Reduced 17.36%
4,480 $317,000
Q1 2017

Jun 04, 2020

BUY
N/A
748 Added 16.01%
5,421 $368,000
Q4 2016

Jun 04, 2020

SELL
N/A
-3,849 Reduced 45.17%
4,673 $335,000
Q3 2016

Jun 04, 2020

SELL
N/A
-413 Reduced 4.62%
8,522 $674,000
Q2 2016

Jun 04, 2020

BUY
N/A
2,195 Added 32.57%
8,935 $745,000
Q1 2016

Jun 04, 2020

BUY
N/A
3,498 Added 107.9%
6,740 $619,000
Q4 2015

Jun 04, 2020

BUY
N/A
480 Added 17.38%
3,242 $328,000
Q3 2015

Jun 04, 2020

BUY
N/A
522 Added 23.3%
2,762 $271,000
Q2 2015

Jun 04, 2020

BUY
N/A
198 Added 9.7%
2,240 $262,000
Q1 2015

Jun 04, 2020

BUY
N/A
2,042 New
2,042 $200,000
Q4 2014

Jun 04, 2020

SELL
N/A
-2,611 Closed
0 $0
Q3 2014

Jun 04, 2020

BUY
N/A
2,611 New
2,611 $278,000
Q2 2014

Jun 04, 2020

SELL
N/A
-4,533 Closed
0 $0
Q1 2014

Jun 04, 2020

BUY
N/A
4,533
4,533 $321,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Choreo, LLC Portfolio

Follow Choreo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choreo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Choreo, LLC with notifications on news.